10501817

Source:http://linkedlifedata.com/resource/pubmed/id/10501817

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007226, umls-concept:C0023977, umls-concept:C0030705, umls-concept:C0032145, umls-concept:C0035648, umls-concept:C0079594, umls-concept:C0085096, umls-concept:C1280500
pubmed:issue	7
pubmed:dateCreated	1999-11-3
pubmed:abstractText	Iloprost, an analogue of prostacyclin, is often utilised in subjects with diabetes mellitus complicated by macroangiopathy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/1256165
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Iloprost, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0031-6970
pubmed:author	pubmed-author:CoppolaLL, pubmed-author:CozzolinoDD, pubmed-author:De LuciaDD, pubmed-author:GentileSS, pubmed-author:MassMM, pubmed-author:SalvatoreTT, pubmed-author:SassoF CFC, pubmed-author:TorellaRR
pubmed:issnType	Print
pubmed:volume	55
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	491-7
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:10501817-Aged, pubmed-meshheading:10501817-Blood Glucose, pubmed-meshheading:10501817-Blood Pressure, pubmed-meshheading:10501817-Cardiovascular Diseases, pubmed-meshheading:10501817-Diabetes Mellitus, Type 2, pubmed-meshheading:10501817-Fasting, pubmed-meshheading:10501817-Female, pubmed-meshheading:10501817-Fibrinogen, pubmed-meshheading:10501817-Hemoglobin A, Glycosylated, pubmed-meshheading:10501817-Humans, pubmed-meshheading:10501817-Iloprost, pubmed-meshheading:10501817-Insulin, pubmed-meshheading:10501817-Male, pubmed-meshheading:10501817-Middle Aged, pubmed-meshheading:10501817-Peripheral Vascular Diseases, pubmed-meshheading:10501817-Pilot Projects, pubmed-meshheading:10501817-Plasminogen, pubmed-meshheading:10501817-Plasminogen Activator Inhibitor 1, pubmed-meshheading:10501817-Platelet Aggregation Inhibitors, pubmed-meshheading:10501817-Risk Factors, pubmed-meshheading:10501817-Time Factors, pubmed-meshheading:10501817-Treatment Outcome, pubmed-meshheading:10501817-Walking
pubmed:year	1999
pubmed:articleTitle	Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1.
pubmed:affiliation	Department of Geriatrics and Metabolic Diseases, II University of Naples, via Cozzolino 116, I-80056-Ercolano, Naples, Italy.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial